bibliographicCitation |
Ni J, Yang L, Zhu H, Chu M, Zhang C, Zhao W, Yang M, Xu X, Zheng E, Jiang X, Li R, Zhao G. A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years: a case report. Ann Palliat Med. 2021 Apr;10(4):4999–5009. doi: 10.21037/apm-21-860. PMID: 33966436. |